Darya Yu. Orlova

Darya Yu. Orlova

Auto-generated profile, based on publicly available information

Darya Yu. Orlova

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2012 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
DODarya Yu. Orlova
Darya Yu. Orlova
LSLenka Stixova
Lenka Stixova
SKStanislav Kozubek
Stanislav Kozubek
HGHinco J. Gierman
Hinco J. Gierman
GŠGabriela Šustáčková
Gabriela Šustáčková
Eva BartovaEva Bartova
Eva Bartova

28 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
GOGuadalupe Ortiz-Muñoz
Guadalupe Ortiz-Muñoz
MBMarkus Brown
Markus Brown
CCCatherine B. Carbone
Catherine B. Carbone
JPJoaquin Pechuan-Jorge
Joaquin Pechuan-Jorge
ARAlex T. Ritter
Alex T. Ritter
CMChristine Moussion
Christine Moussion
Summary: The immune phenotype of a tumor is a key predictor of its response to immunotherapy 1–4 . Patients who respond to immune checkpoint blockade generally present with tumors that are infiltrated by activated T cells, a tumor-immune phenotype referred to as ‘immune inflamed’ 5–7 . However, not all immune inflamed tumors respond to therapy, and in addition the majority of patients presents with tumors that lack T cells (‘immune desert’) or that exclude T cells in the periphery of the tumor islet (‘immune excluded’) 8 . Despite the importance of these tumor-immune phenotypes in patients, little is known about their development, heterogeneity or dynamics due to an inability to model these features pre-clinically. Here, we describe an approach designated STAMP ( s kin t umor a rray by m icro- p oration), which combines in vivo noninvasive, high-throughput time-lapse imaging with excisional biopsies and next generation sequencing to characterize the establishment of the immunological niche and follow its evolution during immunotherapy. STAMP involves the seeding of dozens to hundreds clonal tumors in the superficial dermis of a single mouse ear that can be visualized in situ over weeks to months. Using this approach, we found that genetically identical tumors could display surprisingly different immune phenotypes. Although individual tumors of the same array were populated by the same T cell clonotypes, regression or progression of individual tumors were associated with distinct patterns of spatial organization of the T cells. In situ imaging of 14K tumors revealed that immune phenotypes were not static over-time but could rather evolve with tumor growth and response to treatment. Therapy-induced or spontaneous early conversion to the immune inflamed phenotype correlated with tumor regression and enhanced cytotoxic T cell activity. Therefore, STAMP provides a flexible approach to study the relationship between tumor evolution, immune cell dynamics, and tumor microenvironment with therapeutic response.

1 January 2007 in Siberian Journal of Physics
Verified
Journal Article
Open access
DODarya Yu. Orlova
Darya Yu. Orlova
MYMaxim Yurkin
Maxim Yurkin
KSKonstantin A. Semyanov
Konstantin A. Semyanov
VMValeriy P. Maltsev
Valeriy P. Maltsev

23 March 2018 in Physical Biology
Verified
Journal Article
Closed access
PDF file
YGYu I Glazachev
Yu I Glazachev
DODarya Orlova
Darya Orlova
PŘPetra Řezníčková
Petra Řezníčková
EBEva Bártová
Eva Bártová
We proposed an effective kinetics scheme of photolysis of green fluorescent protein (GFP) observed in live cells with a commercial confocal fluorescence microscope. We investigated the photolysis of GFP-tagged heterochromatin protein, HP1 β -GFP, in live nucleus with the pulse position modulation approach, which has several advantages over the classical pump-and-probe method. At the basis of the proposed scheme lies a process of photoswitching from the native fluorescence state to the intermediate fluorescence state, which has a lower fluorescence yield and recovers back to native state in the dark. This kinetics scheme includes four effective parameters (photoswitching, reverse switching, photodegradation rate constants, and relative brightness of the intermediate state) and covers the time scale from dozens of milliseconds to minutes of the experimental fluorescence kinetics. Additionally, the applicability of the scheme was demonstrated in the cases of continuous irradiation and the classical pump-and-probe approach using numerical calculations and analytical solutions. An interesting finding of experimental data analysis was that the overall photodegradation of GFP proceeds dominantly from the intermediate state, and demonstrated approximately the second-order reaction versus irradiation power. As a practical example, the proposed scheme elucidates the artifacts of fluorescence recovery after the photobleaching method, and allows us to propose some suggestions on how to diminish them.